Our Story
OUR STORY
Body Compass began with a question that became impossible to ignore. What happens after the prescription?
A prescription can begin treatment. But living with what happens next can be much more complicated.
Appetite may change. Fullness may arrive differently. Eating and drinking can become harder. Side effects can interrupt ordinary days. Weight may change quickly, slowly or unpredictably. Food noise may quieten and later return. Progress may plateau. Access, cost, maintenance or stopping treatment may eventually become part of the conversation.
And somewhere inside all of that is a person trying to understand what is happening to their body and what comes next.
Body Compass was created for those questions.
The story began long before Body Compass.
For more than thirty years, P.C. Ennis has worked as a registered nurse across areas including emergency care, community nursing, palliative and end-of-life care, cancer care, aged care, health promotion, leadership, education and patient support.
Across very different areas of healthcare, one pattern kept appearing. A person could receive a diagnosis. They could receive treatment. They could receive instructions. Then they went home and had to live with what happened next.
That space between receiving healthcare and navigating everyday life has always mattered. Years later, GLP-1 treatment made that gap visible in an entirely new way.
Knowing the science did not mean being outside it.
P.C. Ennis also brought her own history to this work. She had lived with obesity. She had experienced bariatric surgery. And eventually, she became a GLP-1 user herself.
That experience brought professional knowledge into direct contact with lived reality. GLP-1 treatment changed hunger. It changed appetite. It quietened food noise in a way that raised a much larger question:
If a biological treatment could change appetite so profoundly, how much of what people had been taught to interpret as willpower had never been willpower alone?
The medication could change the signal. It could not answer every question that followed. What should someone do when eating becomes difficult? How should nourishment and hydration be protected when appetite is dramatically reduced? What happens to muscle and physical function during significant weight loss? What does it mean when food noise begins to return? Why might weight loss slow or stop? Does a changing treatment experience mean the medication has failed? What happens during maintenance? What happens if treatment changes or stops?
The information existed. But it was often fragmented. What was missing was orientation.
That is why it is called Body Compass.
A compass does not tell you exactly where you must go. It does not remove difficult terrain. It does not guarantee that the landscape will stay the same. It helps you orient yourself within it.
Instead of beginning with "What should I do?" Body Compass encourages earlier questions: What is happening? What do we know? What remains uncertain? What deserves attention? What might I need to learn more about? What should I take into a clinical conversation? What is the next sensible step?
The goal is not perfection. It is navigation.
From information to understanding
Body Compass has grown into an education and navigation platform for people considering, using or moving beyond GLP-1 treatment. It includes nurse-written, evidence-informed patient education; free practical resources; guides and tools; books and minibooks; the Living on GLP-1 Treatment education hub; news and evidence updates; The GLP-1 Briefing; structured learning through the Body Compass Navigation Programme; and non-clinical coaching-based navigation support.
Its flagship publication, Beyond the Needle: Navigating GLP-1 Medications in a Changing Landscape, takes the same principle further.
Evidence matters. So does the person living inside it.
Clinical trials matter. Research matters. Regulatory information matters. But evidence describes populations. People live individual lives. Body Compass aims to respect both. Research should be represented accurately. Uncertainty should remain visible. Lived experience can add context, but it should never be presented as proof that everyone will have the same experience. That is why Body Compass describes its work as evidence-informed rather than claiming certainty where certainty does not exist.
The person around the treatment matters too.
Treatment does not happen in isolation. People bring relationships, work, family responsibilities, previous experiences of weight and dieting, expectations, fears, habits, identity and practical barriers into the journey.
P.C. Ennis is also a qualified Results Coach. That training informs another part of the Body Compass approach: helping people reflect on goals, routines, confidence, barriers, adjustment to change and the questions they may want to explore next. Where coaching support is offered through Body Compass, it remains non-clinical. Coaching can support reflection and action. Clinical care assesses and treats health conditions. Body Compass keeps those roles distinct.
Body Compass is neither pro-medication nor anti-medication.
GLP-1 medications can be powerful treatments. They can also involve side effects, limitations, cost, access difficulties, uncertainty and very different experiences between individuals. Some people may remain on treatment long term. Some may change treatment. Some may eventually stop. Body Compass does not begin with a predetermined conclusion about what someone should choose. The aim is better understanding before important decisions are made.
About P.C. Ennis
P.C. Ennis — Registered Nurse | Results Coach | GLP-1 User | Founder, Body Compass
P.C. Ennis is a registered nurse, author, Results Coach and founder of Body Compass. Her professional background spans more than three decades of nursing and healthcare experience, including emergency, community, palliative and end-of-life care, cancer care, aged care, health promotion, clinical leadership, education and patient support.
Her work with Body Compass combines clinical perspective, patient education, current evidence, coaching principles and lived experience of obesity, bariatric surgery and GLP-1 treatment. Her aim is not to tell people what to decide. It is to help them understand the terrain, ask better questions and navigate what comes next with greater clarity.
P.C. Ennis is also a contributor to KevinMD, writing on GLP-1 treatment, patient experience and the realities that sit beyond the prescription.
The landscape will keep changing.
GLP-1 medications, obesity medicine, appetite science and metabolic healthcare are moving quickly. New medications will arrive. Evidence will change. Regulatory decisions will change. Access will change. And new questions will emerge.
Body Compass exists because people deserve information they can understand, contextualise and use as that landscape changes.
We study the terrain. We explain the terrain. We help people navigate it. Walking with you all the way.